Research
Metabolic adaptation
Semaglutide consistently produces substantial reductions in body weight and visceral fat, accompanied by improvements in blood pressure, glycemic control, inflammatory markers, and hepatic steatosis.
Practitioners can expect significant improvements in metabolic health markers with semaglutide use.
StrongSupportsmedium confidence
Across diverse studies, semaglutide consistently produces substantial reductions in body weight and visceral fat, accompanied by improvements in blood pressure, glycemic control, inflammatory markers, and hepatic steatosis.
Why this rating
Based on evidence from multiple studies including randomized trials.
Source
National Consensus on Semaglutide in Cardiology: From Clinical Evidence to Clinical Translation
HK Chopra et al. · Journal of the Association of Physicians of India · 2026
Meta-analysisCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →